Actively Recruiting
Gait Assessment Via Telephone Application
Led by Istanbul University - Cerrahpasa · Updated on 2025-03-24
34
Participants Needed
1
Research Sites
56 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The evaluation of human gait is a crucial component of the clinical assessment and decision-making process. The gold standard in gait analysis is computerized gait analysis, which allows for three-dimensional digital data acquisition through computers (3D Computerized Gait Analysis). However, this technology is not readily accessible in routine analyses, as it proves to be a time-consuming and expensive endeavor in terms of infrastructure and human resources. The utilization of smartphones in clinical applications is on the rise, facilitated by the increasing accessibility of low-cost or free "applications," thereby addressing the limitations associated with traditional gait analysis methods. The Gait-Analyzer application is among the mentioned applications. However, in the literature, no evidence has been found regarding the validity and reliability of Gait-Analyzer application compared to the gold standard 3D computerized gait analysis systems within the context of gait analyses. The aim of this study is to comparatively examine the effectiveness of the Gait-Analyzer smartphone application with established 3D Computerized Gait Analysis systems, which have proven validity and reliability in gait analyses. Through this research, the study intends to elucidate the validity and reliability of spatiotemporal parameters of walking within the Gait-Analyzer smartphone application.
CONDITIONS
Official Title
Gait Assessment Via Telephone Application
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 18 and 26 years
- Body Mass Index (BMI) within normal limits (18.5-24.9 kg/m2)
You will not qualify if you...
- Presence of lower extremity rotational problems such as high femoral anteversion, internal tibial torsion, or metatarsus adductus
- History of Botulinum Toxin Type A (BoNT-A) application or surgery within the last 6 months
- History of lower extremity injury within the last 6 months
- Leg length discrepancy
- Presence of third-degree pes planus
- Any neurological, rheumatic, musculoskeletal, metabolic, or connective tissue diseases
- History of pain, deformity, or surgery related to the vertebral column and upper extremities
- Presence of cognitive, mental, and/or severe psychiatric disorders
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Acibadem Mehmet Ali Aydinlar University
Istanbul, Turkey (Türkiye), 34752
Actively Recruiting
Research Team
A
Ayşenur Erekdağ, MSc
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here